NEWSLETTER

By clicking submit, you agree to share your email address with TFN to receive marketing, updates, and other emails from the site owner. Use the unsubscribe link in the emails to opt out at any time.

Alcon to acquire STAAR Surgical for $1.5B, sharpening focus on vision surgery

STAAR Surgical team
Image credits: STAAR Surgical

Swiss-American pharmaceutical and medtech company Alcon has reached an agreement to acquire STAAR Surgical, a US-based maker of implantable lenses, in a deal valued at about $1.5 billion in total equity. The transaction will see Alcon purchase all outstanding shares of STAAR for $28 each in cash. Both companies’ boards have approved the deal, which now awaits shareholder approval. If cleared, the acquisition is expected to close within six to twelve months.

The move is aimed at strengthening Alcon’s position in the refractive surgery market. STAAR is known for its implantable Collamer lenses, which are used to correct severe myopia and other vision problems without the need for corneal tissue removal. Alcon believes these offerings will complement its own laser vision correction portfolio, creating a more comprehensive range of surgical solutions for patients seeking alternatives to glasses or contact lenses.

Challenges and market conditions

According to BTIG analyst Ryan Zimmerman, the acquisition represents a solid deal for Alcon, particularly in light of STAAR’s recent challenges in China, its largest market. STAAR has faced a slowdown in consumer spending in the country, which has impacted its cash-pay lens business. The economic downturn led to weaker sales, a net loss of roughly $20 million in fiscal 2024, and subsequent layoffs. Despite these setbacks, Zimmerman noted that Alcon is betting on a recovery in China and the broader long-term growth of lens-based refractive surgery.

Growth potential in high myopia treatment

China remains a key market for STAAR due to its large population of people with severe nearsightedness. Alcon highlighted that the global prevalence of high myopia is on the rise, presenting significant growth opportunities for surgical vision correction solutions. By adding STAAR’s lens technology to its existing product suite, Alcon aims to tap into both mature and emerging markets where demand for advanced vision correction options is expanding.

Competitive advantages

The acquisition also brings strategic benefits to Alcon’s surgical division. STAAR’s expertise in implantable lenses gives Alcon a foothold in a segment where it previously had limited exposure, enabling it to compete more effectively against other refractive surgery providers. For STAAR, the deal offers the resources and market reach of a global leader, potentially accelerating adoption of its products worldwide.

Financially, Alcon intends to fund the purchase through a combination of short- and long-term credit facilities. The company anticipates that the acquisition will be accretive to earnings in the second year following its completion. This suggests that while integration and market recovery may take time, the deal is expected to deliver financial benefits over the medium term.

Looking ahead

Pending regulatory and shareholder approvals, the transaction marks a significant step for both companies. STAAR, despite its recent financial difficulties, brings a unique product line and a well-recognised brand in the refractive surgery space. Alcon, with its scale and resources, has the potential to revitalise STAAR’s growth trajectory, particularly in recovering markets like China.

If the acquisition proceeds as planned, patients may benefit from a more integrated range of vision correction solutions under a single provider, potentially improving accessibility to advanced refractive technologies worldwide. For Alcon, the deal not only deepens its product portfolio but also positions it to capture a larger share of the growing demand for surgical vision correction in the years ahead.

Total
0
Shares
Related Posts
Total
0
Share
tfn-logo-2-220x220-removebg-preview

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you
TFN Banner